TSS
CRDF icon

Two Sigma Securities’s Cardiff Oncology CRDF Stock Holding History

Two Sigma Securities’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,102
Closed -$21.2K – 1836
2026
Q1 		$21.2K Buy
+13,102
New +$26.9K ﹤0.01% 1365
2025
Q4 		– Sell
-16,528
Closed -$34K – 1558
2025
Q3 		$34K Buy
+16,528
New +$45.7K 0.01% 1046
2024
Q1 		– Sell
-10,485
Closed -$15.5K – 3060
2023
Q4 		$15.5K Sell
10,485
-9,500
-48% -$11.5K ﹤0.01% 2761
2023
Q3 		$27.8K Buy
+19,985
New +$33.7K ﹤0.01% 2533
2019
Q3 		– Sell
-10,216
Closed -$26K – 2104
2019
Q2 		$26K Buy
+10,216
New +$32.8K ﹤0.01% 1927
2019
Q1 		– Sell
-2,787
Closed -$9K – 1905
2018
Q4 		$9K Buy
2,787
+316
+13% +$1.44K ﹤0.01% 2025
2018
Q3 		$12K Sell
2,471
-196
-7% -$928 ﹤0.01% 2488
2018
Q2 		$12K Buy
+2,667
New +$44.6K ﹤0.01% 2579
2018
Q1 		– Sell
-1,134
Closed -$25K – 2697
2017
Q4 		$25K Buy
1,134
+798
+238% +$35.3K ﹤0.01% 1609
2017
Q3 		$18K Buy
+336
New +$21K ﹤0.01% 837
2017
Q2 		– Sell
-1,674
Closed -$139K – 906
2017
Q1 		$139K Buy
1,674
+1,212
+262% +$165K 0.03% 718
2016
Q4 		$70K Buy
+462
New +$108K 0.02% 579

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Two Sigma Securities's CRDF Position: Q2 2026 in Review

Two Sigma Securities sold out of Cardiff Oncology (CRDF) in Q2 2026, closing a stake of 13,102 shares — an estimated $21.2K sold.

Two Sigma Securities first reported a position in CRDF in Q4 2016 and held it in 12 quarters. The position peaked at $139K in Q1 2017. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Two Sigma Securities reported no remaining Cardiff Oncology position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 13,102 Cardiff Oncology shares in Q2 2026, an estimated $21.2K.
  • Two Sigma Securities first reported a position in Cardiff Oncology in Q4 2016 and held it in 12 quarters.
  • Two Sigma Securities's Cardiff Oncology position peaked at $139K in Q1 2017.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.